Liyue Xi (力月西)力月西
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司
主要成分Active Ingredients
- 咪达唑仑Mida Zuolun
药物知识说明
咪达唑仑是一种在国家药监局注册认定的药品。该药品含有咪达唑仑-c1d9d18d等成分。
该药品关联的活性成分包括：咪达唑仑Mida Zuolun。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司。
您可以探索含有相同成分的其他药品：咪达唑仑-c1d9d18d成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 力月西) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 咪达唑仑Mida Zuolun.
Manufacturers recorded for this product: 江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司.
Explore other medicines containing the same ingredient: 咪达唑仑 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 力月西Recorded Chinese name: 力月西
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:10mg2 mL:10 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏恩华药业股份有限公司Chinese legal name: 江苏恩华药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20031037
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20031037
Manufacturer
Chinese legal name: 江苏恩华药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20031037
生产企业
江苏恩华药业股份有限公司(国产)
适应症
1．麻醉前给药。2．全麻醉诱导和维持。3．椎管内麻醉及局部麻醉时辅助用药。4．诊断或治疗性操作(如心血管造影、心律转复、支气管镜检查、消化道内镜检查等)时病人镇静。5．ICU病人镇静。
用法用量
本品为强镇静药，注射速度宜缓慢，剂量应根据临床需要、病人生理状态、年龄和伍用药物情况而定。 1? 肌内注射 用0.9%氯化钠注射液稀释。 静脉给药 用0.9%氯化钠注射液、5％或10%葡萄糖注射液、5%果糖注 射液、林格氏液稀释。 2? 麻醉前给药 在麻醉诱导前20-60分钟使用，剂量为0.05-0.075mg/kg肌内注射，老年患者剂量酌减;全麻诱导 常用5-10mg(0.1-0.15mg/kg)。 3? 局部麻醉或椎管内麻醉辅助用药，分次静脉注射0.03-0.04mg/kg。 4? ICU病人镇静，先静注2-3mg，继之以0.05mg/(kg・ h)静脉滴注维持。
不良反应
1.较常见的不良反应为嗜睡、镇静过度、头痛、幻觉、共济失调、呃逆和喉痉挛。2.静脉注射还可以发生呼吸抑制及血压下降，极少数可发生呼吸暂停、停止或心跳骤停。有时可发生血栓性静脉炎；3.直肠给药，一些病人可有欣快感。
禁忌
对苯二氮卓过敏的病人、重症肌无力患者、精神分裂症患者、严重抑郁状态患者禁用。
注意事项
1．用作全麻诱导术后常有较长时间再睡眠现象，应注意保持病人气道通畅。2．本品不能用6%葡聚糖注射液或碱性注射液稀释或混合。3．长期静脉注射咪达唑仑，突然撤药可引起戒断综合症，推荐逐渐减少剂量。4．肌内或静脉注射咪达唑仑后至少3个小时不能离开医院或诊室，之后应有人伴随才能离开。至少12个小时内不得开车或操作机器等。5．慎用于体质衰弱者或慢性病、肺阻塞性疾病、慢性肾衰、肝功能损害或充血性心衰病人，若使用咪达唑仑应减小剂量并进行生命体征的监测。
贮藏
遮光，密闭保存。
规格
2ml:10mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.